OptimizeRx Corp | 2013 | FY | 3


During the quarter ended December 31, 2013, the Company corrected an accounting error related to revenue share expenses. The Company will accrue the expense for amounts due, versus when they are paid, for proper matching. The revenue share expense was not properly accrued at the end of 2012 or at the end of each 2013 quarter

 

The restated Consolidated Balance Sheet, Consolidated Statement of Operations and Consolidated Statement of Cash Flows for the year ended December 31, 2012 is as follows:

 

Year ended December 31, 2012        
Financial Statement   Line Item     Corrected       Previously Stated  
Balance sheet   Revenue share payable   $ 90,577     $ 0  
Income statement   Revenue share expense   $ 115,360     $ 24,783  
Income statement   Loss from operations   $ (454,922 )   $ (364,345 )
Income statement   Loss before provision for income taxes   $ (454,553 )   $ (363,976 )
Income statement   Net loss   $ (454,553 )   $ (363,976 )
Statement of cash flows   Net loss   $ (454,553 )   $ (363,976 )
Statement of cash flows   Increase in revenue share payable   $ 90,577     $ 0  


us-gaap:RestatementToPriorYearIncomeTextBlock